Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10?
BTIG Maintains Buy on Oncology Institute, Raises Price Target to $9
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus
Lake Street Initiates Coverage On Oncology Institute with Buy Rating, Announces Price Target of $10
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?
Needham Maintains Buy on Oncology Institute, Raises Price Target to $7
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%
BTIG Maintains Buy on Oncology Institute, Raises Price Target to $8
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
Oncology Institute Says In Follow Up To Nov 2025 Disclosure Of A Cybersecurity Incident, Says A Software Service Provider Detected Unauthorized Access; Vendor Had Unauthorized Access To Information Systems Including Patient Data; Cybersecurity Incident Believed To Affect Other Healthcare Providers; Patient Portal Established; Operations Continue In All Material Respects Since Incident Detection
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00
Oncology Institute Q1 Earnings Call Highlights
The Oncology Institute, Inc. Q1 2026 Earnings Call Summary
ONCOLOGY INSTITUTE INC/THE (NASDAQ:TOI) Beats Q1 Estimates, Raises Free Cash Flow Outlook
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
The Oncology Institute Reports First Quarter 2026 Financial Results
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
Here’s What Powered The Oncology Institute’s (TOI) Gains
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.